Lastest News


Unexpected impacts of the 52 Weekly Working Hour Program into pharmaceutical industry

A revision to the Labor Standards Act which cuts weekly working hours to 52 hours has made concerns among pharmaceutical companies counting for the enforcement. Even through the enforcement will partially impact the ...

9 former-pharmacists elected at 6.13 Local Elections

9 pharmacists gained glory of being elected at the Local Elections on 13 June. According to the National Election Commission, total 9 candidates of the 6.13 Local Elections who were used to be a pharmacist were elect...

SNS contents becoming great sources of marketing for pharmas

The pharmaceutical industry are catching consumers’ eyes with SNS contents as much as like TV advertisements. Their short clips and interesting images have promoted consumers to purchase products with big smiles and s...

Revised medical guidance for dyslipidemia, what would be like?

The Korean Society of Lipid and Atherosclerosis gave a notice of announcement of a revision to the ‘Medical Guidance for Dyslipidemia,’ which attracts the industry over how it would be changed.  The medical guidance ...

Only 6% of patients with experience of taking antidiabetics go to different hospitals

CoreZetta(CEO Hong-Ki Lee), a bio-health care big data analysis company, analyzed the Health Insurance Review and Assessment Service’s big data, and the analysis result showed that most patients who were prescribed fo...

MOHW, “We’ll take a lead in resolving the emergency household medicine issue”

The Ministry of Health and Welfare(MOHW) stressed an opinion of taking in charge of resolving the emergency household medicine issue. This was basically an answer to a concern that part of the industry suggested abou...

274 products approved after 2010, 1 of 5 were ‘anticancer drugs’

1 of 5 new drugs approved in Korea after 2010 were reportedly was anticancer drugs. The Ministry of Food and Drug Safety(MFDS) said 274 products were approved as new drugs in Korea between 2010 and the last year. Th...

Celltrion Healthcare’s ‘Truxima’ expanded to 18 European countries only in 1 year

Celltrion Healthcare is quickly extending the rage of its European distribution network for ‘Truxima(generic name: rituximab),’ an antibody biosimilar for hematologic malignancies. According to Celltrion Healthcare, ...

Kolon Life Science’s osteoarthritis therapy ‘Invossa K’ landed in 60 general hospitals

‘Invossa,’ a gene therapy for osteoarthritis, will start to be prescribed in general hospitals. Kolon Life Science(CEO Woo-Seok Lee) and Mundipharma(CEO Myung-Sae Lee) announced on the 11th that the world’s first and...

South Korea’s National Soccer Team Prepared 2018 Russia World Cup with Vaccination

- 40 national team members were vaccinated including 23 players and the head coach June 11, 2018 Seoul - Sanofi Pasteur in Korea (General Manager: Baptiste de Clarens) announced that it cooperated with the medical co...

MOHW to review 17 products for rare and gynecologic cancers with priority in 2018

Moon Jae-In Care(National Health Insurance Coverage Extension Plan) will gradually cover 415 types of medicines by 2022. This year, 17 anticancer drugs, such as rare cancers and gynecologic cancers, and 71 medicinal ...

Fees to use double- & triple-bed rooms at general hospitals to be decreased by 50% at most

Fees to say at double or triple-bed rooms in superior general hospitals and regular general hospitals will decrease by 50% at most starting 1 July. In addition to this, fees to stay in intensive care units will also ...

12 biologics including 6 influenza vaccines approved last year

Last year, total 12 biologics including 6 influenza vaccines were reported approved. According to the ‘2017 Drug Approval Report’ published by the Ministry of Food and Drug Safety(MFDS), 12 biologic products were app...

Survey starts to understand size and cost of wasted drugs for the first time in Korea

A research will be conducted to take a close look at concrete size and cost of drugs wasted in Korea. The Health Insurance Review and Assessment Service(HIRA) recently gave a notice of tender for the contract researc...

‘Lipiodol’ takes drug price negotiation after being designated as shortage-prevented drug

‘Lipiodol’ which has recently caused controversy with its supply suspension will get on a drug price negotiation after being designated as a shortage-prevented drug. ‘Erbitux’ which ended the drug price negotiation w...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.